Bor-Wen Wu

Title: The Innovations of Bor-Wen Wu

Introduction

Bor-Wen Wu is a prominent inventor based in San Diego, CA, known for his significant contributions to cancer treatment through innovative formulations. With a total of 6 patents, Wu has focused on developing therapies that target arginine depletion, which is crucial in the treatment of various cancers.

Latest Patents

Wu's latest patents include formulations of pegylated arginine deiminase, which provide lyophilized formulations comprising pegylated arginine deiminase (ADI-PEG) and related reconstituted liquid compositions. These compositions are designed for arginine depletion therapies, particularly for treating different types of cancers. Another notable patent involves methods of treatment with arginine deiminase, specifically focusing on the use of pegylated arginine deiminase in cancer therapies.

Career Highlights

Throughout his career, Bor-Wen Wu has worked with several companies, including Polaris Group and Tdw Group. His work has significantly advanced the field of cancer treatment, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

Wu has collaborated with notable colleagues, including John S. Bomalaski and Wei He, who have contributed to his research and development efforts in the field of cancer therapies.

Conclusion

Bor-Wen Wu's innovative work in the development of arginine depletion therapies highlights his commitment to advancing cancer treatment. His contributions through patents and collaborations continue to impact the medical field positively.